Novel Genetic Marker in Ovarian, Lung Cancers - Cancer Network

Novel Genetic Marker in Ovarian, Lung Cancers  Cancer Network

Two new studies found that targeting the cyclin-dependent kinases 4/6 exposed a vulnerability in SMARCA4-deficient cancers.



Comments

Popular posts from this blog

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Oncology: The disease, dynamics & challenges of market research

Respirology | APSR Respiratory Medicine Journal